Page last updated: 2024-08-25

rosiglitazone and Glucose Intolerance

rosiglitazone has been researched along with Glucose Intolerance in 51 studies

Research

Studies (51)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	26 (50.98)	29.6817
2010's	25 (49.02)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, Z; Li, Y; Liu, J; Ma, W; Miranda, KM; Peng, S; Tian, J; Zhang, Y	1
Arteel, GE; Chartoumpekis, DV; Fazzari, M; Freeman, BA; Guimaraes, DA; Khoo, NKH; Li, L; Shiva, S	1
Bennett, PH; Crandall, JP; Edelstein, SL; Goldberg, RB; Kahn, SE; Knowler, WC; Mather, KJ; Mudaliar, S; Nathan, DM; Orchard, TJ; Temprosa, M; White, NH	1
Choi, JM; Jin, SM; Kim, JH; Kim, KW; Lee, S; Oh, BJ; Park, CY; Park, SW; Yang, SJ	1
Asiri, Y; Barr, AM; Boyda, HN; Honer, WG; Lo, R; Pang, CC; Procyshyn, RM; Wang, CK; Wu, C	1
Belchior, T; Blanchard, PG; Carpinelli, A; Chimin, P; Deshaies, Y; Festuccia, WT; Hirabara, SM; Magdalon, J; Marette, A; Paschoal, VA; Simões, D; St-Pierre, P	1
Gu, H; Hinds, TD; Khuder, SS; Lecka-Czernik, B; Najjar, SM; Qiu, B; Russo, L; Sanchez, ER; Stechschulte, LA; Warrier, M; Xu, Y; Yong, W; Zhang, M	1
Baranowski, M; Bryhn, M; Burcelin, R; Cinti, S; Flachs, P; Gorski, J; Hensler, M; Janovska, P; Jelenik, T; Jilkova, Z; Kazdova, L; Kopecky, J; Kuda, O; Kus, V; Mohamed-Ali, V; Ogston, N; Polak, J; Rossmeisl, M	1
Hui, X; Kraegen, EW; Lam, KS; Li, Y; Wang, Y; Wu, D; Xu, A; Zhang, J; Zhu, W	1
Akarca, U; Akyildiz, M; Batur, Y; Cetinkalp, S; Omer, Z; Yilmaz, C; Yilmaz, F	1
Hiukka, A; Koistinen, HA; Kuoppamaa, H; Skrobuk, P	1
Gerstein, HC; Hanley, AJ; Sheridan, P; Yusuf, S; Zinman, B	1
Bassaganya-Riera, J; Guri, AJ; Hontecillas, R	1
Allen, K; Cali, AM; Caprio, S; Pierpont, BM; Savoye, M; Shaw, MM; Taksali, SE	1
Gerstein, HC; Hanley, AJ; Harris, SB; Neuman, J; Qi, Y; Raboud, J; Retnakaran, RR; Zinman, B	1
Swanson, A; Watrin, K; Wilder, L	1
Anand, S; Boyko, EJ; Gerstein, HC; Mohan, V; Shaw, JE; Sheridan, P; Yusuf, S	1
Bruin, JE; Gerstein, HC; Holloway, AC; Hyslop, JR; Petrik, JJ; Raha, S; Tarnopolsky, MA	1
Corrada, E; Ferrante, G; Presbitero, P; Zavalloni, D	1
Malaga, G; Miranda, JJ	1
Casazza, G; Ceriani, E; Costantino, G; Podda, GM	1
Liu, Q; Niu, YJ; Tao, RY; Tian, JY; Ye, F; Zhu, HB; Zhu, P	1
Hanley, AJ; Harris, SB; Qi, Y; Retnakaran, R; Zinman, B	1
Kahn, SE; Utzschneider, KM	1
Fan, MS; Huang, CG; Li, ZX; Sun, ZL; Tang, YH	1
Barr, AM; Boyda, HN; Hawkes, E; Honer, WG; Jin, CH; Pang, CC; Procyshyn, RM; Tse, L	1
Arévalo, MI; Barberà, A; Caelles, C; Gomis, R; Lanuza-Masdeu, J; Vila, C	1
Kazdova, L; Kren, V; Krenova, D; Seda, O	1
Bandyopadhyay, G; Beeson, M; Dizon, M; Farese, RV; Gomez-Daspet, J; Grebenev, D; Kanoh, Y; Miura, A; Powe, J; Sajan, MP; Standaert, ML	1
DeFronzo, RA; He, H; Mandarino, LJ; Miyazaki, Y	1
Alarcon-Aguilar, FJ; Flores-Saenz, JL; Mendez-Francisco, JD; Rivas-Vilchis, JF; Roman-Ramos, R; Trujillo-Arriaga, HM	1
Agrawal, A; Bennett, SM; Elasha, H; Heise, M; Jones, NP; Walker, M; Wilding, JP	1
Durbin, RJ	1
Febbraio, MA; Hawley, JA; Lau, W; Lessard, SJ; Lo Giudice, SL; Reid, JJ; Turner, N; Watt, MJ	1
Asberg, A; Hartmann, A; Hjelmesaeth, J; Jenssen, T; Simonsen, C; Voytovich, MH	1
Ciardullo, AV	1
Hunt, MJ; Morton, AJ	1
Hirosumi, J; Ita, M; Kawamura, I; Mabuchi, M; Manda, T; Minoura, H; Mutoh, S; Seki, J; Takakura, S; Takeshita, S; Yamamoto, T	1
Leiter, EH; Mistry, J; Pan, HJ; Reifsnyder, PC; Xiao, Q; Zhang, W	1
Bullock, M; Cook, C; Gaillard, T; Kaplow, J; Osei, K; Schuster, D	1
Blaak, EE; Hesselink, MK; Mensink, M; Moonen-Kornips, E; Russell, AP; Schaart, G; Schrauwen, P; Sels, JP	1
Fan, SC; He, CT; Hsieh, CH; Hsing Lee, C; Hung, YJ; Kuo, SW; Lin, SH; Pei, D; Sheu, WH	1
Das, S; Maji, D; Roy, RU	1
Gerstein, HC; Hanley, AJ; Harris, SB; Neuman, J; Raboud, JM; Young, TK; Zinman, B	1
Gaillard, T; Osei, K; Schuster, D	1
Abdul Rahman, AR; Ismail, AA; Ismail, SB; Naing, NN; Rahman, S	1
Bruin, JE; Gerstein, HC; Holloway, AC; Petrik, JJ	1
Bosch, J; Budaj, A; Dagenais, GR; Escalante, A; Gerstein, HC; Hedner, T; Holman, R; Keltai, M; Lonn, E; McFarlane, S; McQueen, M; Pogue, J; Sheridan, P; Teo, K; Yusuf, S	1
Anand, SS; Gerstein, HC; McDonald, SD; Sheridan, P; Yusuf, S	1
Blüher, M; Kirsch, K; Kovacs, P; Krist, J; Lehmann, S; Linke, A; Oberbach, A; Sonnabend, M; Stumvoll, M; Tönjes, A	1
Ahima, RS; Bailey, ST; Banerjee, RR; Bhat, S; Brown, EJ; Lazar, MA; Patel, HR; Steppan, CM; Wright, CM	1

Reviews

2 review(s) available for rosiglitazone and Glucose Intolerance

Article	Year
Does diabetes prevention translate into reduced long-term vascular complications of diabetes? Diabetologia, 2019, Volume: 62, Issue:8 Topics: Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Cost-Benefit Analysis; Diabetes Complications; Diabetes Mellitus, Type 2; Follow-Up Studies; Glucose Intolerance; Humans; Hypoglycemic Agents; Life Style; Metformin; Microcirculation; Preventive Medicine; Ramipril; Risk Factors; Rosiglitazone; Treatment Outcome	2019
Clinical Inquiries: How can we keep impaired glucose tolerance and impaired fasting glucose from progressing to diabetes? The Journal of family practice, 2010, Volume: 59, Issue:9 Topics: Acarbose; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Disease Progression; Glucose Intolerance; Humans; Hypoglycemic Agents; Life Style; Prediabetic State; Rosiglitazone; Thiazolidinediones; Weight Loss	2010

Article

Year

Does diabetes prevention translate into reduced long-term vascular complications of diabetes?

Diabetologia, 2019, Volume: 62, Issue:8

Topics: Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Cost-Benefit Analysis; Diabetes Complications; Diabetes Mellitus, Type 2; Follow-Up Studies; Glucose Intolerance; Humans; Hypoglycemic Agents; Life Style; Metformin; Microcirculation; Preventive Medicine; Ramipril; Risk Factors; Rosiglitazone; Treatment Outcome

2019

Clinical Inquiries: How can we keep impaired glucose tolerance and impaired fasting glucose from progressing to diabetes?

The Journal of family practice, 2010, Volume: 59, Issue:9

Topics: Acarbose; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Disease Progression; Glucose Intolerance; Humans; Hypoglycemic Agents; Life Style; Prediabetic State; Rosiglitazone; Thiazolidinediones; Weight Loss

2010

Trials

20 trial(s) available for rosiglitazone and Glucose Intolerance

Article	Year
Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease. European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:1 Topics: Adult; Biopsy; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fatty Liver; Female; gamma-Glutamyltransferase; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Metformin; Middle Aged; Rosiglitazone; Thiazolidinediones; Transaminases; Treatment Outcome	2010
Effect of Rosiglitazone and Ramipril on {beta}-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial. Diabetes care, 2010, Volume: 33, Issue:3 Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Middle Aged; Ramipril; Rosiglitazone; Thiazolidinediones	2010
Rosiglitazone improves glucose metabolism in obese adolescents with impaired glucose tolerance: a pilot study. Obesity (Silver Spring, Md.), 2011, Volume: 19, Issue:1 Topics: Adolescent; Body Composition; Body Weight; Double-Blind Method; Female; Glucose; Glucose Intolerance; Humans; Hypoglycemic Agents; Male; Obesity; Patient Compliance; Pilot Projects; Placebos; Rosiglitazone; Thiazolidinediones; Treatment Outcome	2011
Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study. Lancet (London, England), 2010, Jul-10, Volume: 376, Issue:9735 Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Risk Factors; Rosiglitazone; Thiazolidinediones	2010
Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetic medicine : a journal of the British Diabetic Association, 2010, Volume: 27, Issue:11 Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucose Intolerance; Humans; Hyperglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Ramipril; Risk Assessment; Rosiglitazone; Thiazolidinediones	2010
Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise. Diabetes, 2003, Volume: 52, Issue:8 Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Exercise; Fatty Acids, Nonesterified; Female; Glucose Intolerance; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Isoenzymes; Male; Middle Aged; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Phosphatidylinositol Phosphates; Phosphoproteins; Phosphorylation; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones	2003
Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients. Diabetes, 2003, Volume: 52, Issue:8 Topics: Biopsy; Blood Glucose; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucose Clamp Technique; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Secretion; Male; Middle Aged; Muscle, Skeletal; Phosphoproteins; Phosphorylation; Receptor, Insulin; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Tyrosine	2003
Crossover and double blind study with metformin and rosiglitazone in impaired glucose tolerance subjects. Proceedings of the Western Pharmacology Society, 2003, Volume: 46 Topics: Adult; Area Under Curve; Blood Glucose; Cholesterol, HDL; Cross-Over Studies; Double-Blind Method; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Rosiglitazone; Thiazolidinediones; Triglycerides	2003
Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance. Diabetic medicine : a journal of the British Diabetic Association, 2004, Volume: 21, Issue:5 Topics: Adult; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Postprandial Period; Rosiglitazone; Thiazolidinediones	2004
Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance. Diabetes, obesity & metabolism, 2004, Volume: 6, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Pioglitazone; Prospective Studies; Rosiglitazone; Thiazolidinediones; Treatment Outcome	2004
Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:2 Topics: Blood Glucose; Endothelium, Vascular; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Kidney Transplantation; Male; PPAR gamma; Rosiglitazone; Thiazolidinediones	2005
Discrepancies in the regulation of plasma adiponectin and TNF-alpha levels and adipose tissue gene expression in obese African Americans with glucose intolerance: a pilot study using rosiglitazone. Ethnicity & disease, 2005,Autumn, Volume: 15, Issue:4 Topics: Adiponectin; Adipose Tissue; Adult; Black or African American; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Gene Expression; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Longitudinal Studies; Male; Middle Aged; Obesity; Pilot Projects; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha	2005
Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein. Metabolism: clinical and experimental, 2006, Volume: 55, Issue:4 Topics: Adiponectin; Blood Glucose; C-Reactive Protein; Diabetes Mellitus; Disease Progression; Female; Glucose Intolerance; Glucose Tolerance Test; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Treatment Outcome	2006
Prevention of type 2 diabetes in the prediabetic population. Journal of the Indian Medical Association, 2005, Volume: 103, Issue:11 Topics: Acarbose; Blood Glucose; Diabetes Mellitus, Type 2; Disease Progression; Exercise; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Life Style; Male; Metformin; Prediabetic State; Risk Factors; Rosiglitazone; Thiazolidinediones	2005
Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial. Diabetes, obesity & metabolism, 2006, Volume: 8, Issue:5 Topics: Combined Modality Therapy; Diabetes Mellitus, Type 2; Double-Blind Method; Glucose Intolerance; Humans; Hypoglycemic Agents; Life Style; Metformin; Research Design; Rosiglitazone; Thiazolidinediones; Treatment Outcome	2006
Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone. Metabolism: clinical and experimental, 2007, Volume: 56, Issue:1 Topics: Black People; Blood Glucose; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Liver; Longitudinal Studies; Middle Aged; Pilot Projects; Rosiglitazone; Thiazolidinediones	2007
Effect of rosiglitazone/ramipril on preclinical vasculopathy in newly diagnosed, untreated diabetes and IGT patients: 1-year randomised, double-blind, placebo-controlled study. European journal of clinical pharmacology, 2007, Volume: 63, Issue:8 Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arteries; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Glucose Intolerance; Humans; Hypoglycemic Agents; Middle Aged; Pulsatile Flow; Ramipril; Rosiglitazone; Stroke Volume; Thiazolidinediones; Vascular Diseases	2007
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetes care, 2008, Volume: 31, Issue:5 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Cardiovascular System; Drug Therapy, Combination; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Kidney; Male; Ramipril; Rosiglitazone; Thiazolidinediones	2008
Dysglycemia and a history of reproductive risk factors. Diabetes care, 2008, Volume: 31, Issue:8 Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Middle Aged; Ontario; Parity; Poverty; Pregnancy; Pregnancy Complications; Ramipril; Risk Factors; Rosiglitazone; Thiazolidinediones	2008
Long-term exercise training decreases interleukin-6 (IL-6) serum levels in subjects with impaired glucose tolerance: effect of the -174G/C variant in IL-6 gene. European journal of endocrinology, 2008, Volume: 159, Issue:2 Topics: Diabetes Mellitus, Type 2; Down-Regulation; Exercise; Female; Genotype; Glucose Intolerance; Humans; Hypoglycemic Agents; Interleukin-6; Male; Middle Aged; Physical Endurance; Polymorphism, Single Nucleotide; Rosiglitazone; Thiazolidinediones; Time Factors	2008

Other Studies

29 other study(ies) available for rosiglitazone and Glucose Intolerance

Article	Year
Design and synthesis of rosiglitazone-ferulic acid-nitric oxide donor trihybrids for improving glucose tolerance. European journal of medicinal chemistry, 2019, Jan-15, Volume: 162 Topics: Anti-Inflammatory Agents; Antioxidants; Aquaporin 2; Cells, Cultured; Coumaric Acids; Diabetes Mellitus, Type 2; Drug Design; Glucose Intolerance; Humans; Kidney Tubules, Collecting; Metabolic Syndrome; Microsomes, Liver; Nitric Oxide Donors; Rosiglitazone	2019
Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis. Redox biology, 2019, Volume: 22 Topics: Adipose Tissue; Animals; Biomarkers; Blood Glucose; Body Weight; Diet, High-Fat; Disease Models, Animal; Glucose Intolerance; Hepatocytes; Lipid Metabolism; Male; Mice; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Obesity; Oleic Acids; Protective Agents; Rosiglitazone; Triglycerides	2019
Reduced food intake is the major contributor to the protective effect of rimonabant on islet in established obesity-associated type 2 diabetes. Yonsei medical journal, 2013, Volume: 54, Issue:5 Topics: Adiponectin; Adiposity; Animals; Cell Proliferation; Diabetes Mellitus, Type 2; Eating; Glucose Intolerance; Insulin Resistance; Insulin-Secreting Cells; Male; Piperidines; Pyrazoles; Rats; Rats, Inbred OLETF; Receptor, Cannabinoid, CB1; Rimonabant; Rosiglitazone; Thiazolidinediones	2013
Antidiabetic-drug combination treatment for glucose intolerance in adult female rats treated acutely with olanzapine. Progress in neuro-psychopharmacology & biological psychiatry, 2014, Jan-03, Volume: 48 Topics: Animals; Benzodiazepines; Disease Models, Animal; Drug Therapy, Combination; Fasting; Female; Glucose Intolerance; Glucose Tolerance Test; Glyburide; Hypoglycemic Agents; Insulin; Metformin; Olanzapine; Rats; Rats, Sprague-Dawley; Rosiglitazone; Selective Serotonin Reuptake Inhibitors; Thiazolidinediones; Time Factors	2014
PPARγ activation attenuates glucose intolerance induced by mTOR inhibition with rapamycin in rats. American journal of physiology. Endocrinology and metabolism, 2014, May-01, Volume: 306, Issue:9 Topics: Animals; Cells, Cultured; Drug Antagonism; Glucose Intolerance; Insulin; Insulin-Secreting Cells; Male; Muscle, Skeletal; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sirolimus; Thiazolidinediones; TOR Serine-Threonine Kinases	2014
FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone. Endocrinology, 2016, Volume: 157, Issue:10 Topics: Adiposity; Animals; Energy Metabolism; Fatty Liver; Glucose Intolerance; Intra-Abdominal Fat; Lipid Metabolism; Lipids; Male; Mice, Knockout; Obesity; PPAR gamma; Rosiglitazone; Tacrolimus Binding Proteins; Thiazolidinediones; Weight Gain	2016
n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia, 2009, Volume: 52, Issue:5 Topics: Animals; Corn Oil; Dietary Fats; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Glucose Intolerance; Glycogen; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Rosiglitazone; Thiazolidinediones	2009
Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice. The Journal of biological chemistry, 2009, May-22, Volume: 284, Issue:21 Topics: Animals; Diabetes Mellitus, Experimental; Dietary Fats; Energy Metabolism; Feeding Behavior; Glucose Intolerance; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Mitochondria; Motor Activity; Muscle, Skeletal; Proteins; Proto-Oncogene Proteins c-akt; Recombinant Proteins; Rosiglitazone; Signal Transduction; Thiazolidinediones; Up-Regulation	2009
Acute exposure to rosiglitazone does not affect glucose transport in intact human skeletal muscle. Metabolism: clinical and experimental, 2010, Volume: 59, Issue:2 Topics: Acetyl-CoA Carboxylase; Biological Transport; Body Composition; Glucose; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Muscle, Skeletal; Oxygen Consumption; Phosphorylation; Rosiglitazone; Thiazolidinediones	2010
Abscisic acid synergizes with rosiglitazone to improve glucose tolerance and down-modulate macrophage accumulation in adipose tissue: possible action of the cAMP/PKA/PPAR γ axis. Clinical nutrition (Edinburgh, Scotland), 2010, Volume: 29, Issue:5 Topics: Abscisic Acid; Adipose Tissue; Animals; Blood Glucose; Cyclic AMP-Dependent Protein Kinases; Data Collection; Diabetes Mellitus; Glucose Intolerance; Inflammation; Insulin; Macrophages; Mice; Mice, Obese; Obesity; PPAR gamma; Rosiglitazone; Thiazolidinediones	2010
Rosiglitazone improves pancreatic mitochondrial function in an animal model of dysglycemia: role of the insulin-like growth factor axis. Endocrine, 2010, Volume: 37, Issue:2 Topics: Animals; Diabetes Mellitus, Type 2; Diabetes, Gestational; Disease Models, Animal; Female; Glucose Intolerance; Hypoglycemic Agents; Insulin-Like Growth Factor I; Insulin-Secreting Cells; Mitochondria; Nicotine; Pregnancy; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones	2010
Rosiglitazone plus metformin to prevent type 2 diabetes mellitus. Lancet (London, England), 2010, Oct-23, Volume: 376, Issue:9750 Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucose Intolerance; Humans; Hypoglycemic Agents; Metformin; Rosiglitazone; Thiazolidinediones	2010
Rosiglitazone plus metformin to prevent type 2 diabetes mellitus. Lancet (London, England), 2010, Oct-23, Volume: 376, Issue:9750 Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucose Intolerance; Humans; Hypoglycemic Agents; Metformin; Rosiglitazone; Thiazolidinediones	2010
Rosiglitazone plus metformin to prevent type 2 diabetes mellitus. Lancet (London, England), 2010, Oct-23, Volume: 376, Issue:9750 Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucose Intolerance; Humans; Hypoglycemic Agents; Metformin; Rosiglitazone; Thiazolidinediones	2010
Improvement on lipid metabolic disorder by 3'-deoxyadenosine in high-fat-diet-induced fatty mice. The American journal of Chinese medicine, 2010, Volume: 38, Issue:6 Topics: Animals; Area Under Curve; Cordyceps; Deoxyadenosines; Dietary Fats; Disease Models, Animal; Fenofibrate; Glucose; Glucose Clamp Technique; Glucose Intolerance; Insulin; Insulin Resistance; Lipid Metabolism; Lipid Metabolism Disorders; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Obesity; Phytotherapy; Rosiglitazone; Thiazolidinediones; Weight Gain	2010
Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance. Diabetes care, 2011, Volume: 34, Issue:7 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Rosiglitazone; Thiazolidinediones	2011
What's next for diabetes prevention? Diabetes care, 2011, Volume: 34, Issue:7 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Humans; Insulin-Secreting Cells; Male; Metformin; Rosiglitazone; Thiazolidinediones	2011
Anti-diabetic effects of TongGuanWan, a Chinese traditional herbal formula, in C57BL/KsJ-db/db mice. Planta medica, 2012, Volume: 78, Issue:1 Topics: Acrolein; Administration, Oral; Animals; Berberine; Blood Glucose; Body Weight; Cholesterol, HDL; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Glucose Intolerance; Glycated Hemoglobin; Hypoglycemic Agents; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Phytotherapy; Rosiglitazone; Saponins; Thiazolidinediones; Triglycerides; Xanthones	2012
Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats. Journal of psychiatry & neuroscience : JPN, 2012, Volume: 37, Issue:6 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Female; Glucose Intolerance; Glyburide; Hypoglycemic Agents; Insulin Resistance; Metformin; Olanzapine; Rats; Rosiglitazone; Thiazolidinediones	2012
In vivo JNK activation in pancreatic β-cells leads to glucose intolerance caused by insulin resistance in pancreas. Diabetes, 2013, Volume: 62, Issue:7 Topics: Animals; Glucose Intolerance; Insulin Resistance; Insulin-Secreting Cells; MAP Kinase Kinase 7; MAP Kinase Signaling System; Mice; Mice, Transgenic; Pancreas; Rosiglitazone; Thiazolidinediones	2013
Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain. Physiological genomics, 2003, Jan-15, Volume: 12, Issue:2 Topics: Adipocytes; Adipose Tissue; Administration, Oral; Animals; Body Composition; CD36 Antigens; Diet; Dietary Sucrose; Glucose Intolerance; Glucose Tolerance Test; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Male; Rats; Rats, Inbred BN; Rats, Inbred SHR; Rosiglitazone; Thiazoles; Thiazolidinediones	2003
Rosiglitazone enhances glucose tolerance by mechanisms other than reduction of fatty acid accumulation within skeletal muscle. Endocrinology, 2004, Volume: 145, Issue:12 Topics: Animals; Diglycerides; Fatty Acids; Female; Glucose Intolerance; Hypoglycemic Agents; Muscle, Skeletal; Obesity; Rats; Rats, Zucker; Rosiglitazone; Thiazolidinediones; Triglycerides	2004
Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance: does it really work? If yes, is it a novelty? Diabetic medicine : a journal of the British Diabetic Association, 2005, Volume: 22, Issue:5 Topics: Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Rosiglitazone; Thiazolidinediones	2005
Atypical diabetes associated with inclusion formation in the R6/2 mouse model of Huntington's disease is not improved by treatment with hypoglycaemic agents. Experimental brain research, 2005, Volume: 166, Issue:2 Topics: Administration, Oral; Animals; Behavior, Animal; Diabetes Mellitus; Disease Models, Animal; Exocytosis; Glucose Intolerance; Glyburide; Glycosuria; Huntington Disease; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Neurologic Mutants; Mice, Transgenic; Rosiglitazone; Thiazolidinediones	2005
Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat. European journal of pharmacology, 2005, Sep-05, Volume: 519, Issue:1-2 Topics: Administration, Oral; Animals; Benzimidazoles; Blood Glucose; Dose-Response Relationship, Drug; Glucose; Glucose Intolerance; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Metformin; Pioglitazone; PPAR gamma; Rats; Rats, Zucker; Rosiglitazone; Thiazolidinediones; Time Factors	2005
Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 diabetes. Endocrinology, 2006, Volume: 147, Issue:2 Topics: Adiponectin; Analysis of Variance; Animals; Biomarkers; Diabetes Mellitus, Type 2; Disease Models, Animal; Fatty Liver; Female; Glucose Intolerance; Hypoglycemic Agents; Insulin; Leptin; Male; Mice; Mice, Congenic; Mice, Inbred NOD; Mice, Obese; Obesity; Phenotype; Plasminogen Activator Inhibitor 1; Quantitative Trait, Heritable; Recombination, Genetic; Resistin; Rosiglitazone; Species Specificity; Syndrome; Thiazolidinediones	2006
Reduced skeletal muscle uncoupling protein-3 content in prediabetic subjects and type 2 diabetic patients: restoration by rosiglitazone treatment. The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:4 Topics: Aged; Blood Glucose; Carrier Proteins; Diabetes Mellitus, Type 2; Glucose Clamp Technique; Glucose Intolerance; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Ion Channels; Male; Middle Aged; Mitochondrial Proteins; Muscle, Skeletal; Obesity; Prediabetic State; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Uncoupling Protein 3	2006
Rosiglitazone prevents diabetes by increasing beta-cell mass in an animal model of type 2 diabetes characterized by reduced beta-cell mass at birth. Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:9 Topics: Animals; Animals, Newborn; Apoptosis; Cell Count; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Nicotine; Nicotinic Agonists; Pregnancy; Random Allocation; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones	2008
The hormone resistin links obesity to diabetes. Nature, 2001, Jan-18, Volume: 409, Issue:6818 Topics: 3T3 Cells; Adipocytes; Amino Acid Sequence; Animals; Base Sequence; Chromosomes, Human, Pair 19; Cloning, Molecular; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet; DNA; Female; Gene Expression Regulation; Glucose Intolerance; Hormones; Hormones, Ectopic; Humans; Hypoglycemic Agents; Insulin Antagonists; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Nerve Growth Factor; Neutralization Tests; Obesity; Proteins; Resistin; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones	2001